Douglas A. Treco, Director at CRISPR Therapeutics AG (CRSP), bought 20,000 shares at $57.03 ($1.1M) on 2025-08-06, disclosed to the SEC on 2025-08-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |